About
Aims and scope
Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future by leading authorities.
Editorial Board
For information about Gut Editor-in-Chief Professor Emad El-Omar and his editorial team, please refer to the Editorial Board page.
Ownership
Gut is co-owned by the British Society of Gastroenterology and BMJ.
Journal information
| Publication Model | Subscription; with hybrid open access option |
|---|---|
| Frequency | Monthly |
| Launch date | 1960 |
| Digital Archive | LOCKSS |
Indexed by
Journal statistics (2018)
| Acceptance Rate | 12% |
|---|---|
| Instant Rejection Rate | 66% |
| Time from Submission to First Decision | 10 days 2 – 7 days Fast Track Review |
| Time from Acceptance to Publication | 18 days |
Journal Metrics
Contact information
For all contact information please refer to the Contact Us page.
For authors
Please refer to the Instructions for Authors.
Subscriptions
To advertise
Rights and permissions
Affiliations
Members of the British Society of Gastroenterology receive Frontline Gastroenterology as a benefit of membership; members should login to the British Society of Gastroenterology website to access the journal.
BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve reliability and value of medical research literature by promoting transparent and accurate reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.